Note: Ingredients listed on restricted chemical lists
EC/CAS
201-173-7/79-06-1
Name of the chemical
Acrylamide
Concentration
≥99,9
General Information
Version
1.2
Revision date
2022-07-20
Product name
NU2074 Acrylamide GEN
Substance name
NU2074 Acrylamide GEN
Chemical name
acrylamide; prop-2-enamide
CAS No.
79-06-1
REACH No
01-2119485824-26
1.2.1 Relevant identified uses
Laboratory use
Emergency telephone
+34 937 077 970, 0344 892 0111
Icons in SDS
Company Information
company name
labbox labware s.l
e-mail address of the competent person responsible for the Safety Data Sheet
info@labbox.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H312, H315, H317, H319, H332, H340, H350, H361f, H372
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS06 GHS08
Signal word
Danger
Hazard statements
H350 - May cause cancer. H340 - May cause genetic defects. H361f - Suspected of damaging fertility. H301 - Toxic if swallowed. H372 - Causes damage to organs through prolonged or repeated exposure. H332 - Harmful if inhaled. H312 - Harmful in contact with skin. H319 - Causes serious eye irritation. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction.
Precautionary statements
P201 - Obtain special instructions before use. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308+P313 - IF exposed or concerned: Get medical advice/attention. P304+P340 - IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
